Tenmile
Perth, Western Australiatenmile.com
Overview
Tenmile is a dedicated health technology investment business owned by Tattarang, one of Australia's largest private investment groups. With an initial capital allocation of $250 million, they invest in products and solutions addressing unmet medical needs that support sustainable and equitable healthcare. They focus on providing seed and expansion capital to HealthTech companies with innovative solutions to healthcare needs that fill a gap in existing markets and services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Syndeio Biosciences | May 2025 | Series A | Co-investor |
| AdvanCell | Feb 2025 | Series C | Co-investor |
| Proton Intelligence | Dec 2024 | Seed | Co-investor |
| Xylo Bio | Jun 2024 | Seed | Lead |
| LimmaTech Biologics | Feb 2024 | Series A Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.